Breaking News Instant updates and real-time market news.

AGN

Allergan

$167.63

37.98 (29.29%)

09:47
06/25/19
06/25
09:47
06/25/19
09:47

Allergan rises 29.4%

Allergan is up 29.4%, or $38.05 to $167.62.

AGN Allergan
$167.63

37.98 (29.29%)

06/25/19
MZHO
06/25/19
NO CHANGE
Target $171
MZHO
Buy
Allergan price target lowered to $171 from $194 at Mizuho
Mizuho analyst Irina Koffler lowered her Botox Cosmetic and CoolSculpt estimates after conducting a survey of 20 dermatologists and plastic surgeons, who gave the impression that that the Botox franchise will be pressured by Evolus (EOLS) and other new entrants. Koffler cut her price target on Allergan shares to $171 from $194 based on the lowered estimates, but maintains a Buy rating on the stock, stating that it is "widely expected" that the company will make a strategic announcement that begins the preliminary work of separating the company in the next 1-2 months.
06/25/19
PIPR
06/25/19
NO CHANGE
PIPR
Neutral
Piper says 'willing to listen' to AbbVie reasoning for Allergan acquisition
Ahead of the call to discuss AbbVie's (ABBV) planned $63B acquisition of Allergan (AGN), Piper Jaffray analyst Christopher Raymond said his first reaction to the deal could be summed up with the phrase "two turkeys don't make an eagle," but he is "willing to listen" despite his skepticism about the transaction. Though he cannot say he is "excited at the prospect of AbbVie entering the field of medical aesthetics," EPS accretion of 10% in year one and over 20% at peak, and the potential for meaningful deleveraging and cost cutting, has his attention, Raymond said. He keeps a Neutral rating on AbbVie based on his initial reaction to the deal announcement.
06/25/19
WELS
06/25/19
NO CHANGE
WELS
Outperform
Deals with premiums like Allergan's 'rarely killed,' says Wells Fargo
After Abbvie (ABBV) announced an agreement to acquire Allergan (AGN) for $120 per share of cash and a remaining $68 in AbbVie shares, Wells Fargo analyst David Maris said he views the deal as a good alternative for Allergan versus the current share price, but he is not convinced its a better long term alternative given the eventual biosimilar threat to Abbvie's blockbuster drug Humira. With that said, Maris tells investors that "deals at such premiums are rarely killed because of a bad strategic fit or longer -term value outlook in the absence of other bidders." Though he would not completely rule out an activist investor disrupting the deal, he thinks it is unlikely given there has been a strategic review of the company for some time. Maris, who said he thinks the deal could go through, keeps an Outperform rating on Allergan shares.
06/25/19
LEER
06/25/19
NO CHANGE
LEER
Outperform
Bid of $188 for Allergan 'too low,' others may pursue as well, says SVB Leerink
SVB Leerink analyst Marc Goodman is not surprise that one of the large pharma companies has made a bid on Allergan (AGN) given the multi-year stock weakness. However, he believes a $188 price is "too low," as he "can't believe that Allergan is not being taken out at least at $200," which "begs the question" whether this was a process or is AbbVie (ABBV) "opportunistically pursuing a wounded stock." If it is the latter, Goodman believes this bid could initiate others to pursue Allergan as well. He has an Outperform rating on Allegan's shares.

TODAY'S FREE FLY STORIES

LVMUY

LVMH

$0.00

(0.00%)

13:52
07/15/19
07/15
13:52
07/15/19
13:52
Hot Stocks
LVMH announces partnership with Stella McCartney »

Stella McCartney and LVMH…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

SCHW

Charles Schwab

$40.49

0.47 (1.17%)

13:51
07/15/19
07/15
13:51
07/15/19
13:51
Recommendations
Charles Schwab analyst commentary  »

Wells says Schwab deal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Oct

AMC

AMC Entertainment

$9.45

(0.00%)

13:45
07/15/19
07/15
13:45
07/15/19
13:45
Options
AMC Entertainment call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

SPY

SPDR S&P 500 ETF Trust

$300.31

-0.37 (-0.12%)

, SPX

S&P 500

$0.00

(0.00%)

13:43
07/15/19
07/15
13:43
07/15/19
13:43
Periodicals
Trump ponders firing Commerce Secretary Wilbur Ross, NBC News says »

According to an earlier…

SPY

SPDR S&P 500 ETF Trust

$300.31

-0.37 (-0.12%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDCO

The Medicines Co.

$36.65

-0.03 (-0.08%)

13:35
07/15/19
07/15
13:35
07/15/19
13:35
Options
Medicines Company put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTGN

Neon Therapeutics

$4.61

0.3 (6.96%)

13:30
07/15/19
07/15
13:30
07/15/19
13:30
Recommendations
Neon Therapeutics analyst commentary  »

Neon Therapeutics'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

SYMC

Symantec

$21.73

-3.83 (-14.98%)

, AVGO

Broadcom

$289.18

3.79 (1.33%)

13:27
07/15/19
07/15
13:27
07/15/19
13:27
Periodicals
Broadcom was willing to pay up $28.25 per share for Symantec, Reuters reports »

Symantec (SYMC) walked…

SYMC

Symantec

$21.73

-3.83 (-14.98%)

AVGO

Broadcom

$289.18

3.79 (1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CARA

Cara Therapeutics

$25.55

1.25 (5.14%)

13:25
07/15/19
07/15
13:25
07/15/19
13:25
Options
Cara Therapeutics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
07/15/19
07/15
13:25
07/15/19
13:25
Conference/Events
Stephens consumer/poultry & egg analysts hold analyst/industry conference call »

Analysts provide an…

A

Agilent

$69.90

-1.75 (-2.44%)

13:25
07/15/19
07/15
13:25
07/15/19
13:25
Conference/Events
The Brookings Institution to hold a conference »

8th annual Municipal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jul

GOOG

Alphabet

$1,146.02

1.47 (0.13%)

, GOOGL

Alphabet Class A

$1,146.04

0.74 (0.06%)

13:24
07/15/19
07/15
13:24
07/15/19
13:24
Periodicals
Trump administration 'taking aim' at Google, FBN's Gasparino says »

Charles Gasparino of Fox…

GOOG

Alphabet

$1,146.02

1.47 (0.13%)

GOOGL

Alphabet Class A

$1,146.04

0.74 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 25

    Jul

  • 08

    Aug

  • 27

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
07/15/19
07/15
13:17
07/15/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
07/15/19
07/15
13:16
07/15/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLF

Herbalife Nutrition

$41.12

-0.47 (-1.13%)

13:15
07/15/19
07/15
13:15
07/15/19
13:15
Options
Herbalife put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

OSAGY

Osram

$0.00

(0.00%)

13:09
07/15/19
07/15
13:09
07/15/19
13:09
Hot Stocks
Osram announces interest from AMS, sees 'rather low' probability of deal »

Osram Licht said it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAESY

BAE Systems

$0.00

(0.00%)

13:09
07/15/19
07/15
13:09
07/15/19
13:09
Hot Stocks
BAE Systems reports award of $45M contract from U.S. Army »

The U.S. Army has awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBGI

Sinclair Broadcast

$58.58

-0.46 (-0.78%)

, GIII

G-III Apparel

$28.05

-0.36 (-1.27%)

13:07
07/15/19
07/15
13:07
07/15/19
13:07
On The Fly
Fly Insider: G-III, Target among week's notable insider transactions »

Welcome to "Fly Insider,"…

SBGI

Sinclair Broadcast

$58.58

-0.46 (-0.78%)

GIII

G-III Apparel

$28.05

-0.36 (-1.27%)

OPK

Opko Health

$2.14

-0.025 (-1.15%)

THO

Thor Industries

$58.96

-0.4 (-0.67%)

GEF

Greif

$33.90

-0.68 (-1.97%)

INSG

Inseego

$5.19

0.03 (0.58%)

FDS

FactSet

$293.90

-2.66 (-0.90%)

TREE

LendingTree

$428.63

-4.28 (-0.99%)

MKC

McCormick

$159.84

1.31 (0.83%)

TGT

Target

$86.80

-0.73 (-0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 12

    Aug

  • 21

    Aug

  • 05

    Sep

  • 19

    Sep

  • 19

    Sep

  • 25

    Sep

  • 13

    Nov

YELP

Yelp

$35.68

-0.37 (-1.03%)

13:05
07/15/19
07/15
13:05
07/15/19
13:05
Options
Yelp call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CONN

Conn's

$18.07

-0.21 (-1.15%)

13:03
07/15/19
07/15
13:03
07/15/19
13:03
Hot Stocks
Conn's settles with SEC over underwriting policies, bad debt provisions »

Conn's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

ET

Energy Transfer LP

$14.82

(0.00%)

13:02
07/15/19
07/15
13:02
07/15/19
13:02
Hot Stocks
Energy Transfer LP announce binding supplemental open season for Bakken »

Energy Transfer LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$45.86

-0.17 (-0.37%)

13:02
07/15/19
07/15
13:02
07/15/19
13:02
Hot Stocks
Blackstone agrees to acquire Vungle, terms not disclosed »

Blackstone announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

BIDU

Baidu

$115.31

0.41 (0.36%)

, SNAP

Snap

$15.59

-0.01 (-0.06%)

13:02
07/15/19
07/15
13:02
07/15/19
13:02
Hot Stocks
Baidu, Snap renew sales partnership »

Baidu (BIDU) and Snap…

BIDU

Baidu

$115.31

0.41 (0.36%)

SNAP

Snap

$15.59

-0.01 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 23

    Jul

INTC

Intel

$49.91

(0.00%)

, AMD

AMD

$34.42

1.22 (3.67%)

12:56
07/15/19
07/15
12:56
07/15/19
12:56
Recommendations
Intel, AMD analyst commentary at RBC Capital »

RBC sees AMD continuing…

INTC

Intel

$49.91

(0.00%)

AMD

AMD

$34.42

1.22 (3.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

FB

Facebook

$203.64

-1.265 (-0.62%)

12:52
07/15/19
07/15
12:52
07/15/19
12:52
Hot Stocks
Facebook's Marcus says company won't immediately profit from Libra »

In testimony for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 24

    Jul

CYTK

Cytokinetics

$11.04

0.02 (0.18%)

, AMGN

Amgen

$177.08

2.21 (1.26%)

12:51
07/15/19
07/15
12:51
07/15/19
12:51
Recommendations
Cytokinetics, Amgen analyst commentary at Piper Jaffray »

Piper reiterates…

CYTK

Cytokinetics

$11.04

0.02 (0.18%)

AMGN

Amgen

$177.08

2.21 (1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 09

    Sep

  • 16

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.